These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 25299732)

  • 1. Casein kinase 1δ/ε inhibitor PF-5006739 attenuates opioid drug-seeking behavior.
    Wager TT; Chandrasekaran RY; Bradley J; Rubitski D; Berke H; Mente S; Butler T; Doran A; Chang C; Fisher K; Knafels J; Liu S; Ohren J; Marconi M; DeMarco G; Sneed B; Walton K; Horton D; Rosado A; Mead A
    ACS Chem Neurosci; 2014 Dec; 5(12):1253-65. PubMed ID: 25299732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective inhibition of casein kinase 1 epsilon minimally alters circadian clock period.
    Walton KM; Fisher K; Rubitski D; Marconi M; Meng QJ; Sládek M; Adams J; Bass M; Chandrasekaran R; Butler T; Griffor M; Rajamohan F; Serpa M; Chen Y; Claffey M; Hastings M; Loudon A; Maywood E; Ohren J; Doran A; Wager TT
    J Pharmacol Exp Ther; 2009 Aug; 330(2):430-9. PubMed ID: 19458106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine D3/D2 Receptor Antagonist PF-4363467 Attenuates Opioid Drug-Seeking Behavior without Concomitant D2 Side Effects.
    Wager TT; Chappie T; Horton D; Chandrasekaran RY; Samas B; Dunn-Sims ER; Hsu C; Nawreen N; Vanase-Frawley MA; O'Connor RE; Schmidt CJ; Dlugolenski K; Stratman NC; Majchrzak MJ; Kormos BL; Nguyen DP; Sawant-Basak A; Mead AN
    ACS Chem Neurosci; 2017 Jan; 8(1):165-177. PubMed ID: 27715007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and Profiling of a Selective and Brain Penetrant Radioligand for in Vivo Target Occupancy Measurement of Casein Kinase 1 (CK1) Inhibitors.
    Wager TT; Galatsis P; Chandrasekaran RY; Butler TW; Li J; Zhang L; Mente S; Subramanyam C; Liu S; Doran AC; Chang C; Fisher K; Grimwood S; Hedde JR; Marconi M; Schildknegt K
    ACS Chem Neurosci; 2017 Sep; 8(9):1995-2004. PubMed ID: 28609096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Casein kinase 1δ activity: a key element in the zebrafish circadian timing system.
    Smadja Storz S; Tovin A; Mracek P; Alon S; Foulkes NS; Gothilf Y
    PLoS One; 2013; 8(1):e54189. PubMed ID: 23349822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An inhibitor of casein kinase I epsilon induces phase delays in circadian rhythms under free-running and entrained conditions.
    Badura L; Swanson T; Adamowicz W; Adams J; Cianfrogna J; Fisher K; Holland J; Kleiman R; Nelson F; Reynolds L; St Germain K; Schaeffer E; Tate B; Sprouse J
    J Pharmacol Exp Ther; 2007 Aug; 322(2):730-8. PubMed ID: 17502429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3,4-Diaryl-isoxazoles and -imidazoles as potent dual inhibitors of p38alpha mitogen activated protein kinase and casein kinase 1delta.
    Peifer C; Abadleh M; Bischof J; Hauser D; Schattel V; Hirner H; Knippschild U; Laufer S
    J Med Chem; 2009 Dec; 52(23):7618-30. PubMed ID: 19591487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 is phosphorylated in vitro and in vivo by the delta and epsilon isoforms of casein kinase 1 and enhances the level of casein kinase 1 delta in response to topoisomerase-directed drugs.
    Knippschild U; Milne DM; Campbell LE; DeMaggio AJ; Christenson E; Hoekstra MF; Meek DW
    Oncogene; 1997 Oct; 15(14):1727-36. PubMed ID: 9349507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological characterization of 2-methyl-N-((2'-(pyrrolidin-1-ylsulfonyl)biphenyl-4-yl)methyl)propan-1-amine (PF-04455242), a high-affinity antagonist selective for κ-opioid receptors.
    Grimwood S; Lu Y; Schmidt AW; Vanase-Frawley MA; Sawant-Basak A; Miller E; McLean S; Freeman J; Wong S; McLaughlin JP; Verhoest PR
    J Pharmacol Exp Ther; 2011 Nov; 339(2):555-66. PubMed ID: 21821697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel dual agonist of glucagon-like peptide-1 receptors and neuropeptide Y2 receptors attenuates fentanyl taking and seeking in male rats.
    Zhang Y; Rahematpura S; Ragnini KH; Moreno A; Stecyk KS; Kahng MW; Milliken BT; Hayes MR; Doyle RP; Schmidt HD
    Neuropharmacology; 2021 Jul; 192():108599. PubMed ID: 33965397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autokinase Activity of Casein Kinase 1 δ/ε Governs the Period of Mammalian Circadian Rhythms.
    Guo G; Wang K; Hu SS; Tian T; Liu P; Mori T; Chen P; Johnson CH; Qin X
    J Biol Rhythms; 2019 Oct; 34(5):482-496. PubMed ID: 31392916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic treatment with a selective inhibitor of casein kinase I delta/epsilon yields cumulative phase delays in circadian rhythms.
    Sprouse J; Reynolds L; Kleiman R; Tate B; Swanson TA; Pickard GE
    Psychopharmacology (Berl); 2010 Jul; 210(4):569-76. PubMed ID: 20407760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The selective phosphodiesterase 9 (PDE9) inhibitor PF-04447943 (6-[(3S,4S)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-1-(tetrahydro-2H-pyran-4-yl)-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one) enhances synaptic plasticity and cognitive function in rodents.
    Hutson PH; Finger EN; Magliaro BC; Smith SM; Converso A; Sanderson PE; Mullins D; Hyde LA; Eschle BK; Turnbull Z; Sloan H; Guzzi M; Zhang X; Wang A; Rindgen D; Mazzola R; Vivian JA; Eddins D; Uslaner JM; Bednar R; Gambone C; Le-Mair W; Marino MJ; Sachs N; Xu G; Parmentier-Batteur S
    Neuropharmacology; 2011 Sep; 61(4):665-76. PubMed ID: 21619887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SLV330, a cannabinoid CB(1) receptor antagonist, attenuates ethanol and nicotine seeking and improves inhibitory response control in rats.
    de Bruin NM; Lange JH; Kruse CG; Herremans AH; Schoffelmeer AN; van Drimmelen M; De Vries TJ
    Behav Brain Res; 2011 Mar; 217(2):408-15. PubMed ID: 21074574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Casein Kinase 1δ Inhibitors as Promising Therapeutic Agents for Neurodegenerative Disorders.
    Catarzi D; Varano F; Vigiani E; Lambertucci C; Spinaci A; Volpini R; Colotta V
    Curr Med Chem; 2022; 29(27):4698-4737. PubMed ID: 35232339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Baclofen prevents drug-induced reinstatement of extinguished nicotine-seeking behaviour and nicotine place preference in rodents.
    Fattore L; Spano MS; Cossu G; Scherma M; Fratta W; Fadda P
    Eur Neuropsychopharmacol; 2009 Jul; 19(7):487-98. PubMed ID: 19250803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic Targeting of Casein Kinase 1δ/ε in an Alzheimer's Disease Mouse Model.
    Adler P; Mayne J; Walker K; Ning Z; Figeys D
    J Proteome Res; 2019 Sep; 18(9):3383-3393. PubMed ID: 31334659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-(1H-Pyrazol-3-yl)quinazolin-4-amines as a novel class of casein kinase 1δ/ε inhibitors: Synthesis, biological evaluation and molecular modeling studies.
    Karthikeyan C; Jharia P; Waiker DK; Nusbaum AC; Amawi H; Kirwen EM; Christman R; Arudra SKC; Meijer L; Tiwari AK; Trivedi P
    Bioorg Med Chem Lett; 2017 Jun; 27(12):2663-2667. PubMed ID: 28487075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2-Benzamido-N-(1H-benzo[d]imidazol-2-yl)thiazole-4-carboxamide derivatives as potent inhibitors of CK1δ/ε.
    Bischof J; Leban J; Zaja M; Grothey A; Radunsky B; Othersen O; Strobl S; Vitt D; Knippschild U
    Amino Acids; 2012 Oct; 43(4):1577-91. PubMed ID: 22331384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of casein kinase I epsilon/delta produces phase shifts in the circadian rhythms of Cynomolgus monkeys.
    Sprouse J; Reynolds L; Swanson TA; Engwall M
    Psychopharmacology (Berl); 2009 Jul; 204(4):735-42. PubMed ID: 19277609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.